LXRX
Lexicon Pharmaceuticals Inc
Price:  
1.61 
USD
Volume:  
2,280,283.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX EV/EBITDA

-994.4%
Upside

As of 2024-05-23, the EV/EBITDA ratio of Lexicon Pharmaceuticals Inc (LXRX) is -2.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LXRX's latest enterprise value is 399.83 mil USD. LXRX's TTM EBITDA according to its financial statements is -176.69 mil USD. Dividing these 2 quantities gives us the above LXRX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.0x - 23.4x 18.6x
Forward P/E multiples 18.5x - 22.9x 21.5x
Fair Price (13.32) - (16.42) (14.40)
Upside -927.1% - -1119.7% -994.4%
1.61 USD
Stock Price
(14.40) USD
Fair Price

LXRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-23 -2.26
2024-05-22 -2.35
2024-05-21 -2.35
2024-05-20 -2.49
2024-05-17 -2.49
2024-05-16 -2.58
2024-05-15 -2.72
2024-05-14 -2.69
2024-05-13 -2.63
2024-05-10 -2.51
2024-05-09 -2.65
2024-05-08 -2.49
2024-05-07 -2.49
2024-05-06 -2.57
2024-05-03 -2.44
2024-05-02 -2.39
2024-05-01 -2.32
2024-04-30 -2.17
2024-04-29 -2.19
2024-04-26 -2.22
2024-04-25 -2.17
2024-04-24 -2.25
2024-04-23 -2.26
2024-04-22 -2.40
2024-04-19 -2.32
2024-04-18 -2.29
2024-04-17 -2.28
2024-04-16 -2.38
2024-04-15 -2.63
2024-04-12 -2.76
2024-04-11 -2.85
2024-04-10 -2.83
2024-04-09 -2.90
2024-04-08 -2.93
2024-04-05 -2.89
2024-04-04 -2.89
2024-04-03 -2.86
2024-04-02 -3.10
2024-04-01 -3.20
2024-03-28 -3.36
2024-03-27 -3.07
2024-03-26 -2.78
2024-03-25 -2.97
2024-03-22 -3.17
2024-03-21 -3.38
2024-03-20 -3.49
2024-03-19 -3.42
2024-03-18 -3.53
2024-03-15 -3.64
2024-03-14 -3.41